HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 287/6/H2746    most recent 00493.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Kristo, G. Articles by Lasley, R. D. Search for Related Content PubMed PubMed Citation Articles by Kristo, G. Articles by Lasley, R. D.

Adenosine A₁/A_2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning

Department of Surgery, University of Kentucky College of Medicine, Lexington, Kentucky 40536-0298

Submitted 27 May 2004 ; accepted in final form 19 July 2004

The purpose of this study was to determine whether the adenosine A₁/A_2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning. Regional stunning was produced by 15 min of coronary artery occlusion and 3 h of reperfusion (RP) in anesthetized open-chest pigs. In acute protection studies, animals were pretreated with saline, low-dose AMP-579 (15 µg/kg iv bolus 10 min before ischemia), or high-dose AMP-579 (50 µg/kg iv at 14 µg/kg bolus + 1.2 µg·kg^–1·min^–1 for 30 min before coronary occlusion). The delayed preconditioning effects of AMP-579 were evaluated 24 h after administration of saline vehicle or high-dose AMP-579 (50 µg/kg iv). Load-insensitive contractility was assessed by measuring regional preload recruitable stroke work (PRSW) and PRSW area. Acute preconditioning with AMP-579 dose dependently improved regional PRSW: 129 ± 5 and 100 ± 2% in high- and low-dose AMP-579 groups, respectively, and 78 ± 5% in the control group at 3 h of RP. Administration of the adenosine A₁ receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (0.7 mg/kg) blocked the acute protective effect of high-dose AMP-579, indicating that these effects are mediated through A₁ receptor activation. Delayed preconditioning with AMP-579 significantly increased recovery of PRSW area: 64 ± 5 vs. 33 ± 5% in control at 3 h of RP. In isolated perfused rat heart studies, kinetics of the onset and washout of AMP-579 A₁ and A_2a receptor-mediated effects were distinct compared with those of other adenosine receptor agonists. The unique nature of the adenosine agonist AMP-579 may play a role in its ability to induce delayed preconditioning against in vivo myocardial stunning.

adenosine receptors; ischemia-reperfusion

This article has been cited by other articles:

				R. R. Morrison, B. Teng, P. J. Oldenburg, L. C. Katwa, J. B. Schnermann, and S. J. Mustafa Effects of targeted deletion of A1 adenosine receptors on postischemic cardiac function and expression of adenosine receptor subtypes Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1875 - H1882. [Abstract] [Full Text] [PDF]

				G. Kristo, Y. Yoshimura, B. J. Keith, R. M. Mentzer Jr., and R. D. Lasley Aged Rat Myocardium Exhibits Normal Adenosine Receptor-Mediated Bradycardia and Coronary Vasodilation But Increased Adenosine Agonist-Mediated Cardioprotection J. Gerontol. A Biol. Sci. Med. Sci., November 1, 2005; 60(11): 1399 - 1404. [Abstract] [Full Text] [PDF]

				R. D. Lasley, B. J. Keith, G. Kristo, Y. Yoshimura, and R. M. Mentzer Jr. Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H785 - H791. [Abstract] [Full Text] [PDF]

				E. A. Reid, G. Kristo, Y. Yoshimura, C. Ballard-Croft, B. J. Keith, R. M. Mentzer Jr, and R. D. Lasley In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2253 - H2259. [Abstract] [Full Text] [PDF]